Archean ChemicalQ1 FY27
Archean Chemical Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹501P/E: 63.5Market Cap: ₹6.1K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Bromine volumes are expected to reach a run rate of 20,000 to 25,000 tons by the end of FY27 and aim for about 25,000 tons in FY28.
- →Industry growth for bromine is projected to be low to mid single digits annually.
- →Expansion to 28,500 tons of bromine merchant sales could be achievable around FY28-FY29 with additional investments.
- →Salt volumes are anticipated to normalize and grow with a double-digit increase expected from Q3 onwards as logistics issues resolve.
- →Drilling and oilfield chemicals demand remains stable with ongoing development of new products, some in customer trials, expecting meaningful volumes in the second half of FY27.
- →Semiconductor project capex and constructions start in late FY26, with full commercial operations expected 24-27 months after start, contributing to long-term growth.
- →The derivatives business recently turned EBITDA positive and is expected to scale up earnings and volumes.
Margin guidance
Category 3- →Q1 FY27 showed strong sequential growth: standalone revenue +9%, EBITDA +26.3%, PAT +36%.
- →Bromine volumes expected to reach 20,000-25,000 tons run rate by year-end and about 25,000 tons in FY28.
- →Derivatives business (Acume) turned EBITDA positive and continues scaling with new product launches.
- →Sulphate of Potash (SOP) trials progressing; phase 2 completion by Q3 FY27 expected to enable commercial scale-up.
- →Semiconductor project (SiCSem) in execution phase; medium-term growth driver starting FY28 and beyond.
- →Oilfield chemicals business scaling slowly; customer trials underway for mud chemicals and pack/starch products.
- →Logistics improvements and cost optimizations expected to improve margins in H2 FY27.
- →Capex of approx. USD 249 million for semiconductor project; 60-65% to be incurred in FY27, rest in FY28.
- →Confident of delivering double-digit growth from Q3 FY27 in salt and bromine businesses.
- →EPS growth driven by volume ramp-ups, derivative scale-up, and operational efficiencies over next 2-3 years.
3 more insights locked — sign up free to unlock
Fundraise plans
- →The transcript does not explicitly mention any current or planned new fundraising through debt or equity.
- →Rajeev Kumar mentioned that the semiconductor project has a total capex of USD 249 million, with 15-20% already incurred, about 60-65% expected in the current financial year, and the balance in the next year. However, this is an ongoing project expenditure rather than new fundraising.
- →The company is focused on stronger cash flow and disciplined capital allocation.
- →No direct references were made to plans for raising additional debt or equity financing in the near term during this call.
Order book
The provided pages from the Archean Chemical Industries Limited document do not explicitly mention current, expected orderbook, or pending orders details. However, from the discussion, a few relevant points can be inferred:
- There have been order deferments affecting salt shipments due to conflicts in the Middle East (QVC orders postponed).
- Logistics challenges have caused delays but there is no mention of lost orders.
- Customer relationships remain strong, with no reported loss of orders despite commercial discipline exercised on some contracts.
- Bromine and derivatives demand remains stable with ongoing customer trials and new account additions.
- The company expects to liquidate existing inventory as normal through the rest of the year.
For precise current or expected orderbook figures, further detailed financial disclosures or sections outside the provided text would be required.
Capex plans
Yes- →Semicon project capex: USD 249 million total
- → - 15%-20% already incurred
- → - 60%-65% to be spent in FY27 (this financial year), mainly for advances for plant, machinery, and equipment
- → - Remaining 40%-45% in FY28 (next financial year)
- →Expansion plans for bromine production:
- → - Targeting 20,000-25,000 tons run rate by end of FY27
- → - 40,000 tons run rate expected by FY28-29 requiring further investment aligned with flame retardant project and capacity expansion
- →New product development in drilling chemicals (pack, starch, bentonite, barite):
- → - Customer trials ongoing
- → - Expect meaningful volumes from H2 FY27 onwards for pack and starch and by end of FY27 for bentonite and barite
- →Offgrid and advanced materials investments:
- → - Offgrid pilot plant started
- → - Investing in long-term opportunities with expected value accretion over 24-48 months
- →Infrastructure and logistics:
- → - Expanded ports and fleet to improve efficiency; benefits expected from Q3 FY27 onwards
How does Archean Chemical rank vs peers in Chemicals & Petrochemicals?
Pro feature1Archean Chemical
Rev 3Mar 3
See full Chemicals & Petrochemicals sector rankings
How does Archean Chemical rank in Chemicals & Petrochemicals?
Compare Archean Chemical against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.